🌍·Apr 14Industry
https://sellaslifesciences.com/
Publisher
S
SELLAS Life Sciences
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- SELLAS Life Sciences
- Region
- 最新
- Scope
- Industry
- Published
- April 14, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on sellaslifesciences.com
Leave the platform to read the original full article on the publisher site.
Source: SELLAS Life Sciences
Scope: Industry
Related coverage
More related coverage
Bristol-Myers Squibb News/4h ago
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
GSK News/8h ago
Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer
Santen Pharmaceutical/15h ago
Santen and KYORIN announce joint marketing agreement in Japan for allergic conjunctivitis treatment Alesion® Eyelid Cream 0.5%
Otsuka Holdings RSS/15h ago